Clinical status and outcomes in mRS grades
| N | mRS 0–2 % (n) | mRS 3 % (n) | mRS 4–5 % (n) | mRS 6 % (n) | |
| Pre-hemorrhage, n=84/84 (100%) | 84 | 98.8% (83) | 1.2% (1) | 0% (0) | 0% (0) |
| Discharge, n=84/84 (100%) | 84 | 70.2% (59) | 8.3% (7) | 13.2% (11) | 8.3% (7) |
| FU1 (3–6 months), n=75/77 (97.4%) | 75 | 85.3% (64) | 2.7% (2) | 8% (6) | 4% (3) |
| FU2 (9–18 months), n=40/74 (54%) | 40 | 97.5% (39) | 0% (0) | 2.5% (1) | 0% (0) |
| FU3 (>19 months), n=15/74 (20.3%) | 15 | 93.3% (14) | 0% (1) | 6.7% (0) | 0% (0) |
| Latest possible mRS, n=84 (100%) | 84 | 76.2% (64) | 3.6% (3) | 8.3% (7) | 11.9% (10) |
FU, follow-up; mRS, modified Rankin Scale.